24 related articles for article (PubMed ID: 32552466)
1. Reconfigurable hybrid interface for molecular marker diagnostics and in-situ reporting.
Ehrhardt K; Guinn MT; Quarton T; Zhang MQ; Bleris L
Biosens Bioelectron; 2015 Dec; 74():744-50. PubMed ID: 26210472
[TBL] [Abstract][Full Text] [Related]
2. Application of Molecular Profiling in Colorectal Cancer Surgery.
Ding PR
Clin Colon Rectal Surg; 2023 Nov; 36(6):367-368. PubMed ID: 37795467
[No Abstract] [Full Text] [Related]
3. Stage-specific treatment of colorectal cancer: A microRNA-nanocomposite approach.
Fadaka AO; Akinsoji T; Klein A; Madiehe AM; Meyer M; Keyster M; Sikhwivhilu LM; Sibuyi NRS
J Pharm Anal; 2023 Nov; 13(11):1235-1251. PubMed ID: 38174117
[TBL] [Abstract][Full Text] [Related]
4. A GNAS Gene Mutation's Independent Expression in the Growth of Colorectal Cancer: A Systematic Review and Meta-Analysis.
Afolabi HA; Salleh SM; Zakaria Z; Ch'ng ES; Mohd Nafi SN; Abdul Aziz AAB; Irekeola AA; Wada Y; Al-Mhanna SB
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428574
[TBL] [Abstract][Full Text] [Related]
5. Curcumin Targeting Non-Coding RNAs in Colorectal Cancer: Therapeutic and Biomarker Implications.
Li J; Chai R; Chen Y; Zhao S; Bian Y; Wang X
Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291546
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-based regulation of Aurora A kinase in breast cancer.
Fadaka AO; Sibuyi NRS; Madiehe AM; Meyer M
Oncotarget; 2020 Nov; 11(46):4306-4324. PubMed ID: 33245732
[TBL] [Abstract][Full Text] [Related]
7. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated microRNAs participate in the crosstalk between colorectal cancer and atrial fibrillation.
Ding J; Cao Y; Qi C; Zong Z
Hum Cell; 2023 Jul; 36(4):1336-1342. PubMed ID: 36964414
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
10. Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression.
Kandhavelu J; Subramanian K; Khan A; Omar A; Ruff P; Penny C
Microrna; 2019; 8(1):68-75. PubMed ID: 30073936
[TBL] [Abstract][Full Text] [Related]
11. Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapy.
Manceau G; Imbeaud S; Thiébaut R; Liébaert F; Fontaine K; Rousseau F; Génin B; Le Corre D; Didelot A; Vincent M; Bachet JB; Chibaudel B; Bouché O; Landi B; Bibeau F; Leroy K; Penault-Llorca F; Van Laethem JL; Demetter P; Tejpar S; Rossi S; Mosakhani N; Osterlund P; Ristamäki R; Sarhadi V; Knuutila S; Boige V; André T; Laurent-Puig P
Clin Cancer Res; 2014 Jun; 20(12):3338-47. PubMed ID: 24771647
[TBL] [Abstract][Full Text] [Related]
12. Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis.
Gungormez C; Gumushan Aktas H; Dilsiz N; Borazan E
Mol Biol Rep; 2019 Aug; 46(4):4175-4183. PubMed ID: 31123908
[TBL] [Abstract][Full Text] [Related]
13. In silico identification of microRNAs as candidate colorectal cancer biomarkers.
Fadaka AO; Klein A; Pretorius A
Tumour Biol; 2019 Nov; 41(11):1010428319883721. PubMed ID: 31718480
[TBL] [Abstract][Full Text] [Related]
14. Genomic profiling of microRNA target genes in colorectal cancer.
Fadaka AO; Bakare OO; Pretorius A; Klein A
Tumour Biol; 2020 Jun; 42(6):1010428320933512. PubMed ID: 32552466
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
